Surviving Brain Cancer During Pregnancy
Antonia Reyes was 39 years old and 18 weeks pregnant when an MRI revealed an apparent glioma in the right temporal-parietal lobe region.
Special Report on Immunotherapy: Managing Yervoy's Side Effects
As an immunotherapy, Yervoy presents a unique set of side effects and it was approved along with a Risk Evaluation and Mitigation Strategy to address these events.
Nurse Navigators and Community Health Workers: Building Unique Relationships for Cancer Care, Part I of II
With the current economic strife we are facing in healthcare today, finding ways to deliver quality survivorship care for cancer patients has become a tremendous challenge for oncology nurse navigators.
Genetic Counseling in Cancer Care: What Is the Role of Oncology Nurses?
If you saw a patient who was under 50 and had breast, colon, or ovarian cancer, what course of action would you recommend?
Genetic Testing for Cancer Susceptibility: Clinical Utility, Direct-to-Consumer Marketing, and Ensuring Results Are Properly Interpreted
Although genetic testing for cancer susceptibility is a simple process of blood sampling, the interpretation of the results may be rather complicated.
Relacorilant/Nab-Paclitaxel Is Convenient, Safe in Ovarian Cancer
Neoadjuvant Nivolumab Regimen Improves OS in Resectable NSCLC
Relacorilant Combo Boosts PFS in Resistant Ovarian Cancer
Nivolumab/Ipilimumab To Be New MSI-H/dMMR mCRC Standard of Care
